Research Center: The Woolcock Institute of Medical Research
Location: Various, Sydney and surrounds
Lead Doctor: Dr. Christine Jenkins
Ethics Committee: This study has been reviewed and approved by Northern Sydney Local Health District Human Research Ethics Committee

Researcher Interview: 

 
Audio Player

Background

Over 13% of Australians are smokers and at risk of developing Chronic Obstructive Pulmonary Disease (COPD), which includes Chronic Bronchitis and Emphysema.

This study is investigating whether a safe treatment can  slow down or even prevent the development of COPD in smokers.  

This study seeks healthy smokers aged 25 – 55 years old who do not have any lung condition. Participants are required to take a puffer daily and attend 4 study visits at the research site over 12 months. Participants will be reimbursed up to $200 for their time.

Benefits of Participation

• You may reduce the effects of smoking on your lungs.
• You will receive an assessment of your lung function.
• You will get assistance to stop smoking.
• You will be compensated $50 if you attend a screening visit
• If deemed eligible, you will be compensated $50 per clinic visit thereafter (x3)
• You will go into a draw to receive 1 of 2 gift cards worth $500
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 25 – 55 years old
• Do not regularly use e-cigarettes
• No diagnosis of COPD, asthma or other lung condition
• Not taking regular lung-related medication
• Not a frequent user of THC (more than once per week)
• Able to attend 4 study visits at the research site over approximately 12 months